TJ

The Journal of Infectious Diseases

The Journal of Infectious Diseases is an Oxford Academic journal affiliated with the Infectious Diseases Society of America that publishes research and commentary in infectious diseases and offers both subscription access and optional open access publishing.

Looking to publish in The Journal of Infectious Diseases? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Immunology, Infectious Diseases
Impact Factor 4.5
Quartile Q2
Open Access Type Hybrid
ISSN 0022-1899
eISSN 1537-6613
Invitation Only No
Cost Range Standard license: no license charge. OA article processing charge: $5,001. Page composition charges: $125 per finished typeset page.

Submission Instructions

The Journal of Infectious Diseases accepts the following article types. Click on an article type to view submission instructions.

Major Articles

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required and must be provided as the second page of the manuscript. Abstract must be no more than 250 words. Abstract must be structured. Abstract must use the headings Background, Methods, Results, and Conclusions.
Manuscript Major Articles must not exceed 3500 words. Manuscript must include a Methods section detailed enough to allow readers to repeat the study without referring to supplementary material. Title page must include a 40-word summary of the article’s main point.
References Major Articles are limited to 40 references. References must be numbered consecutively as they appear in the text, with the numbers in brackets on the text line.
Figures & Tables Major Articles are limited to 7 figures and tables combined. Tables must be on separate pages. Tables and figures must be numbered consecutively by appearance, each table must have a legend or title, and each figure must have a legend.
Reformat to The Journal of Infectious Diseases using Livewrite Premium

Brief Reports

Cover Letter Cover Letter requirements are not specified.
Abstract Brief Reports must include an abstract. The abstract must be unstructured and must not exceed 100 words. The abstract must be unstructured.
Manuscript Brief Reports must not exceed 1500 words. The text must be ordered as Background, Methods, Results, and Discussion. The methods section must be sufficiently detailed to allow readers to repeat the study without referring to supplementary material.
References Brief Reports are limited to 15 references. References must be numbered consecutively as they appear in the text, with the numbers in brackets on the text line.
Figures & Tables Brief Reports are limited to 2 figures and tables combined. Tables must be on separate pages.
Reformat to The Journal of Infectious Diseases using Livewrite Premium

Correspondence

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Manuscript must not exceed 750 words. Correspondence must respond to an article published in the journal within the preceding 12 months and be prepared in manuscript format including a title page.
References References are limited to 10. References must be numbered consecutively as they appear in the text, with the numbers in brackets on the text line.
Figures & Tables Correspondence is limited to 1 figure or table. Tables must be on separate pages. Tables and figures must be numbered consecutively by appearance, and each table or figure must include a legend or title.
Reformat to The Journal of Infectious Diseases using Livewrite Premium

Recent Publications

Safety and Immunogenicity of a PD-1-Enhanced HIV-1 Therapeutic DNA Vaccine: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I Clinical Trial in People With HIV-1 on Antiretroviral Therapy

Qiaoli Peng, Yik Chun Wong, Wing Yin Cheng, Yun He, Chengxi Xie, Yirong Shi, Ting Wang, Yanhua Du, Xiaoyun Yang, Zhongfang Wang, Hui Wang, Hongzhou Lu, Zhiwei Chen, Xia Jin

10.1093/infdis/jiag320
View Publication

Randomized, Double-Blind, Placebo-Controlled First-in-Human Trial of a First-in-Class AI-Designed Monoclonal Antibody (GB-0669) Against the Conserved SARS-CoV-2 Spike S2 Stem Helix

Francesco Borriello, Gavin C K W Koh, Iñaki F Troconiz, Rounak Nassirpour, Lovely Goyal, Anvar Suyundikov, Akber Safder, Nicholas Robertson, Anna Allen, Andrew Robertson, Stephanie Straley, Pam Farmer, Denise Murphy, Eric Carlin, Kimberly P Schmitt, Amarendra Pegu, Daria Hazuda, Alexandra Snyder, Dinesh P De Alwis

10.1093/infdis/jiag349
View Publication

Afucosylated VAR2CSA-Specific IgG Reduces Risks of Placental Malaria

Honghua Ding, Oscar H Lloyd Williams, Maria Saeed, Wina Hasang, Bruce D Wines, Mary Lopez-Perez, Maria del Pilar Quintana, Lars Hviid, Adam Wheatley, Mwayiwawo Madanitsa, Victor Mwapasa, Kamija S Phiri, Feiko O ter Kuile, Nichollas Scott, Elizabeth H Aitken, Stephen J Rogerson

10.1093/infdis/jiag344
View Publication

Correction to: Ubiquitination Defect of X-Linked Inhibitor of Apoptosis Protein as a Novel Susceptibility to Invasive Fungal Pneumonia

-

10.1093/infdis/jiag355
View Publication

Influenza Attack Rates and Vaccine Effectiveness by Prior-Season Infection and Vaccination: A 17-Season Analysis

Naoki Kawai, Takuma Bando, Takashi Kawashima, Shinro Matsuura, Tetsunari Maeda, Woon Joo Lee, Shin Nagao, Hareaki Yamamoto, Kazuo Mori, Tokunao Amemiya, Osame Tanaka, Ken-ichi Doniwa, Ietaka Satoh, Hideyuki Ikematsu

10.1093/infdis/jiag352
View Publication

Frequently asked questions

How long does it take to publish?

A review pathway is offered for papers previously peer reviewed at another medical journal to speed publication and minimize unnecessary re-review.

Reformat to The Journal of Infectious Diseases using Livewrite Premium

Is a cover letter required?

Cover letters are not required. The submission system collects the information previously provided in cover letters, including a brief pitch. A cover letter explanation is needed if an alternative control was used in experiments involving genetically engineered mice.

Reformat to The Journal of Infectious Diseases using Livewrite Premium

What are the publication costs?

Research Topics

HIV Research and Treatment Respiratory viral infections research Viral gastroenteritis research and epidemiology Herpesvirus Infections and Treatments Cytomegalovirus and herpesvirus research HIV/AIDS Research and Interventions Pneumonia and Respiratory Infections Influenza Virus Research Studies Hepatitis B Virus Studies Viral Infections and Vectors HIV/AIDS drug development and treatment Mosquito-borne diseases and control Bacterial Infections and Vaccines Mycobacterium research and diagnosis Hepatitis C virus research Malaria Research and Control Antimicrobial Resistance in Staphylococcus Reproductive tract infections research Immune Cell Function and Interaction Streptococcal Infections and Treatments Immune Response and Inflammation Tuberculosis Research and Epidemiology Escherichia coli research studies Virology and Viral Diseases Diverse Scientific and Economic Studies

Related Journals

IA
Infection and Immunity American Society for Microbiology
AO
Annals of Allergy Asthma & Immunology Elsevier BV
JF
Journal for ImmunoTherapy of Cancer BMJ
JO
Journal of Immunotherapy and Precision Oncology Innovative Healthcare Institute
ID
Infectious Diseases and Therapy Adis, Springer Healthcare
PE
Parasite Epidemiology and Control Elsevier BV